NLRC3 Participates in Inhibiting the Pulmonary Inflammatory Response of Sepsis-Induced Acute Lung Injury

ABSTRACT Acute lung injury (ALI) progresses rapidly, is difficult to treat, and has a high fatality rate. The excessive inflammatory response is an important pathological mechanism of ALI. NLRC3 (NLR family CARD domain-containing 3), a non-inflammasome member of the NLR family, has been found that it could negatively regulates various biological pathways associated with inflammatory response, such as NF-κB (nuclear factor kappa B), PI3K (Phosphatidylinositol 3′-kinase)-Akt (protein kinase B)-mTOR (mammalian target of the rapamycin), and STING (stimulator of interferon genes) pathways, which are responsible for the progression of pulmonary inflammation and participate in regulating the pathological progression of ALI. However, the effects of NLRC3 in sepsis-induced pathological injury of lung tissue remain unclear. In this study, we aimed to investigate the potential effects of NLRC3 in the sepsis-induced ALI. To investigate whether NLRC3 participates in inhibiting the pulmonary inflammatory response of sepsis-induced ALI. Sepsis-induced ALI mice models were established by intrabronchial injection of lipopolysaccharide (LPS) or cecum ligation and puncture (CLP). The lentivirus with overexpression of NLRC3 (LV-NLRC3) and downregulation of NLRC3 (LV-NLRC3-RNAi) were transfected to LPS-induced ALI mice. The expression of NLRC3 was upregulated or downregulated in the lung tissue of sepsis-induced ALI mice. Transfection with NLRC3-overexpression lentivirus significantly decreased inflammatory response in the lung of LPS-induced ALI mice in contrast to the control group. By transfection with NLRC3-silencing lentivirus, the inflammatory response in LPS-induced ALI mice was aggravated. Our study provides evidence of the protective effect of NLRC3 in sepsis-induced ALI by inhibiting excessive inflammatory response of the lung tissue. AbbreviationsAcute lung injury: ALI; intensive care units: ICU; lipopolysaccharide: LPS; acute respiratory distress syndrome: ARDS; bronchoalveolar lavage fluid: BALF; nucleotide-binding oligomerization domain-like receptors: NLRs; NLR family CARD domain containing 3: NLRC3; nuclear factor kappa B: NF-κB; tumor necrosis factor receptor-associated factor 6: TRAF6; Phosphatidylinositol 3′-kinase: PI3K; protein kinase B: Akt; mammalian target of the rapamycin: mTOR; stimulator of interferon genes: STING; TANK-binding kinase 1: TBK1; type I interferon: IFN-I; toll-like receptors: TLRs; tumor necrosis factor: TNF; interleukin: IL; NOD-like receptor protein 3: NLRP3; enhanced green fluorescent protein: EGFP; lentivirus: LV; phosphate-buffered saline: PBS; intrabronchial: i.t.; cecum ligation and puncture: CLP; wet/dry: W/D; Real time polymerase chain reaction: RT-PCR; enzyme-linked immunosorbent assay: ELISA; hematoxylin and eosin: H&E; radio immunoprecipitation assay: RIPA; sodium dodecyl sulfate polyacrylamide gel electrophoresis: SDS-PAGE; polyvinylidene fluoride: PVDF; glyceraldehyde 3-phosphate dehydrogenase: GAPDH; bovine serum albumin: BSA; Tris buffered saline containing Tween 20: TBST; standard deviation: SD; one-way analysis of variance: ANOVA; janus kinase 2: JAK2; activators of transcription 3: STAT3; pathogen associated molecular patterns: PAMPs; danger associated molecular patterns: DAMPs.

[1]  Ruiting Li,et al.  Overview of the anti-inflammatory function of the innate immune sensor NLRC3. , 2022, Molecular immunology.

[2]  Yuyu Li,et al.  AKR1C1 alleviates LPS-induced ALI in mice by activating the JAK2/STAT3 signaling pathway , 2021, Molecular medicine reports.

[3]  Vijay Kumar.  Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury , 2020, Frontiers in Immunology.

[4]  Q. Su,et al.  NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL‐6/JAK2/STAT3 pathway activation , 2020, Cell biology international.

[5]  Jun Zhou,et al.  NLRC3 inhibits PDGF‐induced PASMCs proliferation via PI3K‐mTOR pathway , 2020, Journal of cellular physiology.

[6]  K. Hibbert,et al.  Recent advances in the understanding and management of ARDS , 2019, F1000Research.

[7]  Yu-hong Yuan,et al.  NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling , 2019, Cell Death & Disease.

[8]  Ruirui Li,et al.  Mitochondrial Coenzyme Q Protects Sepsis-Induced Acute Lung Injury by Activating PI3K/Akt/GSK-3β/mTOR Pathway in Rats , 2019, BioMed research international.

[9]  Bo Hu,et al.  [Corrigendum] HMGB1 participates in LPS‑induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF‑κB signaling pathways. , 2019, International journal of molecular medicine.

[10]  Bo Hu,et al.  HMGB1 participates in LPS-induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF-κB signaling pathways , 2019, International journal of molecular medicine.

[11]  X. Zhong,et al.  NLRC3 expression in dendritic cells attenuates CD4+ T cell response and autoimmunity , 2019, The EMBO journal.

[12]  Xiaoping Yang,et al.  Glycyrrhizic acid ameliorates LPS-induced acute lung injury by regulating autophagy through the PI3K/AKT/mTOR pathway. , 2019, American journal of translational research.

[13]  Y. Xiong,et al.  Dehydrocostus Lactone Suppresses LPS-induced Acute Lung Injury and Macrophage Activation through NF-κB Signaling Pathway Mediated by p38 MAPK and Akt , 2019, Molecules.

[14]  H. Ke,et al.  Viral DNA Binding to NLRC3, an Inhibitory Nucleic Acid Sensor, Unleashes STING, a Cyclic Dinucleotide Receptor that Activates Type I Interferon , 2019, Immunity.

[15]  M. Matthay,et al.  Pathogenesis of Acute Respiratory Distress Syndrome , 2019, Seminars in Respiratory and Critical Care Medicine.

[16]  J. Ting,et al.  The Innate Immune Sensor NLRC3 Acts as a Rheostat that Fine‐Tunes T Cell Responses in Infection and Autoimmunity , 2018, Immunity.

[17]  Hui Luo,et al.  NLRC3: A Novel Noninvasive Biomarker for Pulmonary Hypertension Diagnosis , 2018, Aging and disease.

[18]  Hai-Yan Qiu,et al.  Effects of Artesunate on chondrocyte proliferation, apoptosis and autophagy through the PI3K/AKT/mTOR signaling pathway in rat models with rheumatoid arthritis. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  Bing Liu,et al.  HMGB1 regulates T helper 2 and T helper17 cell differentiation both directly and indirectly in asthmatic mice , 2018, Molecular immunology.

[20]  Katsiaryna V. Gris,et al.  NLR-Dependent Regulation of Inflammation in Multiple Sclerosis , 2018, Front. Immunol..

[21]  T. Kanneganti,et al.  NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer , 2017, Cell cycle.

[22]  E. Eren,et al.  NLRC3 protein inhibits inflammation by disrupting NALP3 inflammasome assembly via competition with the adaptor protein ASC for pro-caspase-1 binding , 2017, The Journal of Biological Chemistry.

[23]  Si Ming Man,et al.  NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer , 2016, Nature.

[24]  V. Dixit,et al.  Inflammasomes: mechanism of assembly, regulation and signalling , 2016, Nature Reviews Immunology.

[25]  K. Fitzgerald,et al.  Inflammasome Complexes: Emerging Mechanisms and Effector Functions , 2016, Cell.

[26]  T. Allen,et al.  Acute Lung Injury: A Clinical and Molecular Review. , 2016, Archives of pathology & laboratory medicine.

[27]  E. Eren,et al.  Overexpressed NLRC3 Acts as an Anti-Inflammatory Cytosolic Protein , 2014, Journal of Innate Immunity.

[28]  I. C. Allen.  Non-Inflammasome Forming NLRs in Inflammation and Tumorigenesis , 2014, Front. Immunol..

[29]  B. Koller,et al.  The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κB , 2012, Nature Immunology.